FDA Issues Warning to Chemco Corporation Regarding Drug Product Violations

The U.S. Food and Drug Administration has sent a warning letter to Chemco Corporation. This action addresses concerns over the company's finished pharmaceutical products. Violations cited include the marketing of unapproved new drugs and misbranding, raising questions about product quality and safety.